Tazeen Ahmad Downgraded (BCRX) to Sell and Increased Target to $3 on, Jul 31st, 2013
Tazeen Ahmad of B of A Securities, Downgraded "BioCryst Pharmaceuticals, Inc." (BCRX) to Sell and Increased Target from $2 to $3 on, Jul 31st, 2013.
Tazeen, nor any peers, have made any analyst calls on BCRX in the last 4 months.
Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30Similar Automotive and Transportation Articles
[ Fri, Jul 12th 2013
] - WOPRAI
[ Thu, Jul 11th 2013
] - WOPRAI
[ Fri, May 17th 2013
] - WOPRAI
[ Tue, May 14th 2013
] - WOPRAI
[ Wed, Apr 17th 2013
] - WOPRAI
[ Fri, Apr 12th 2013
] - WOPRAI
[ Wed, Apr 03rd 2013
] - WOPRAI
[ Fri, Mar 08th 2013
] - WOPRAI